PROK looking good at 2.00The potential is there. May be just under 4 level target. Both volume and price action is there.
Next report date
Report period
Q1 2024
EPS estimate
−4.86MXN
Revenue estimate
—
−9.71MXN
−602.43 MMXN
43.34 M
About ProKidney Corp.
Sector
Industry
CEO
Bruce Culleton
Website
Headquarters
Winston-Salem
Employees (FY)
163
Founded
2015
FIGI
BBG014RL5C02
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PROK/N is 36.80 MXN — it has decreased by 0.54% in the past 24 hours. Watch PROKIDNEY CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange PROKIDNEY CORP stocks are traded under the ticker PROK/N.
PROKIDNEY CORP is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
PROK/N stock is 1.59% volatile and has beta coefficient of 1.68. Track PROKIDNEY CORP stock price on the chart and check out the list of the most volatile stocks — is PROKIDNEY CORP there?
PROK/N earnings for the last quarter are −3.14 MXN per share, whereas the estimation was −2.75 MXN resulting in a −14.02% surprise. The estimated earnings for the next quarter are −2.43 MXN per share. See more details about PROKIDNEY CORP earnings.
Yes, you can track PROKIDNEY CORP financials in yearly and quarterly reports right on TradingView.
PROK/N stock has fallen by 23.76% compared to the previous week, the month change is a 56.20% rise, over the last year PROKIDNEY CORP has showed a 72.34% decrease.
PROK/N net income for the last quarter is −96.83 M MXN, while the quarter before that showed −191.46 M MXN of net income which accounts for 49.42% change. Track more PROKIDNEY CORP financial stats to get the full picture.
Today PROKIDNEY CORP has the market capitalization of 2.30 B, it has increased by 12.95% over the last week.
No, PROK/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PROK/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROKIDNEY CORP stock right from TradingView charts — choose your broker and connect to your account.
As of May 4, 2024, the company has 163.00 employees. See our rating of the largest employees — is PROKIDNEY CORP on this list?
We've gathered analysts' opinions on PROKIDNEY CORP future price: according to them, PROK/N price has a max estimate of 102.50 MXN and a min estimate of 34.17 MXN. Watch PROK/N chart and read a more detailed PROKIDNEY CORP stock forecast: see what analysts think of PROKIDNEY CORP and suggest that you do with its stocks.